<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: symptom relief</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Post-approval TAVI registry shows high rates of device success at one year</title>
   	 <description>One-year results from SOURCE XT – one of the largest, post-approval transcatheter aortic valve implantation (TAVI) registries to-date – reported today at EuroPCR 2013 show good clinical outcomes in routine clinical practice, with high rates of device success for all access approaches, valve sizes and delivery systems.</description>
     <link>http://medicalxpress.com/news/2013-05-post-approval-tavi-registry-high-device.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 21 May 2013 17:16:00 EST</pubDate>
	 <guid isPermaLink="false">news288375191</guid>
	 
</item>
<item>
     <title>Hastings Center calls on health care professionals and organizations to meet standards for good care near the end of lif</title>
   	 <description>People with chronic or life-threatening illnesses often experience problems with their care, including confusion and conflict over how to make good decisions, poor communication with care providers, inadequate pain and symptom relief, and treatments with little or no benefit. Poor care decreases patients' quality of life, increases family stress, and adds cost but not value to health care, often with heartbreaking financial consequences for families. A new set of consensus guidelines produced by The Hastings Center can help health care professionals improve care near the end of life. The guidelines clarify what is ethically and legally permissible in the United States regarding the use life-sustaining technologies, provide in-depth guidance on talking with patients and surrogates, and offer recommendations about how to improve the delivery of care.</description>
     <link>http://medicalxpress.com/news/2013-05-hastings-center-health-professionals-standards.html</link>
	 <category>Health</category>
	 <pubDate>Tue, 07 May 2013 12:35:22 EST</pubDate>
	 <guid isPermaLink="false">news287148911</guid>
	 
</item>
<item>
     <title>Oral drops can give kids needle-free relief from asthma, allergies</title>
   	 <description>Allergy shots are commonly used to treat children with severe environmental allergies and asthma, but under-the-tongue drops may offer yet another beneficial—and stick-free—option for pediatric allergy sufferers, according to a Johns Hopkins Children's Center review of existing scientific evidence.</description>
     <link>http://medicalxpress.com/news/2013-05-oral-kids-needle-free-relief-asthma.html</link>
	 <category>Immunology</category>
	 <pubDate>Mon, 06 May 2013 05:10:02 EST</pubDate>
	 <guid isPermaLink="false">news287034597</guid>
	 
</item>
<item>
     <title>'Oil for the joints' offers hope for osteoarthritis sufferers</title>
   	 <description>A team of researchers led by a Boston University Biomedical Engineer has developed a new joint lubricant that could bring longer lasting relief to millions of osteoarthritis sufferers. The new synthetic polymer supplements synovial fluid, the natural lubricant in joints, and works better than comparable treatments currently available.</description>
     <link>http://medicalxpress.com/news/2013-05-oil-joints-osteoarthritis.html</link>
	 <category>Arthritis &amp; Rheumatism</category>
	 <pubDate>Thu, 02 May 2013 16:42:33 EST</pubDate>
	 <guid isPermaLink="false">news286731746</guid>
	 
</item>
<item>
     <title>Common gene variants explain 42% of antidepressant response</title>
   	 <description>Antidepressants are commonly prescribed for the treatment of depression, but many individuals do not experience symptom relief from treatment. The National Institute of Mental Health's STAR*D study, the largest and longest study ever conducted to evaluate depression treatment, found that only approximately one-third of patients responded within their initial medication trial and approximately one-third of patients did not have an adequate clinical response after being treated with several different medications. Thus, identifying predictors of antidepressant response could help to guide the treatment of this disorder.</description>
     <link>http://medicalxpress.com/news/2013-03-common-gene-variants-antidepressant-response.html</link>
	 <category>Psychology &amp; Psychiatry</category>
	 <pubDate>Thu, 28 Mar 2013 08:38:59 EST</pubDate>
	 <guid isPermaLink="false">news283678728</guid>
	 
</item>
<item>
     <title>In some dystonia cases, deep brain therapy benefits may linger after device turned off</title>
   	 <description>Two patients freed from severe to disabling effects of dystonia through deep brain stimulation therapy continued to have symptom relief for months after their devices accidentally were fully or partly turned off, according to a report published online Feb. 11 in the journal Movement Disorders.</description>
     <link>http://medicalxpress.com/news/2013-02-dystonia-cases-deep-brain-therapy.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Tue, 12 Feb 2013 17:03:19 EST</pubDate>
	 <guid isPermaLink="false">news279910984</guid>
	 
</item>
<item>
     <title>Back pain intensity most influential in fusion decision</title>
   	 <description>(HealthDay)—Patients seeing a spine surgeon are most influenced by low back pain intensity when considering whether to proceed with spinal fusion surgery, according to a study published in the Jan. 15 issue of Spine.</description>
     <link>http://medicalxpress.com/news/2013-01-pain-intensity-influential-fusion-decision.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 24 Jan 2013 18:20:01 EST</pubDate>
	 <guid isPermaLink="false">news278272579</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/backpaininte.jpg" width="90" height="90" />
</item>
<item>
     <title>No strong evidence to back use of cannabis extract in multiple sclerosis</title>
   	 <description>There is no strong evidence to back the use of cannabis extract in the treatment of Multiple Sclerosis (MS), concludes a review of the available evidence on the first licensed preparation, published in the December issue of Drug and Therapeutics Bulletin (DTB).</description>
     <link>http://medicalxpress.com/news/2012-12-strong-evidence-cannabis-multiple-sclerosis.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Wed, 12 Dec 2012 18:30:05 EST</pubDate>
	 <guid isPermaLink="false">news274554384</guid>
	 
</item>
<item>
     <title>Researchers find decline in availability and use of key treatment for depression</title>
   	 <description>Electroconvulsive therapy (ECT) is considered the most effective treatment option for patients with severe depression who cannot find symptom relief through antidepressant medications or psychotherapy. In a new study, researchers at Butler Hospital and Bradley Hospital in Rhode Island found a sharp decline in the availability and use of ECT in general hospitals across the U.S. The findings were published online in the journal Biological Psychiatry on October 10, 2012.</description>
     <link>http://medicalxpress.com/news/2012-11-decline-availability-key-treatment-depression.html</link>
	 <category>Psychology &amp; Psychiatry</category>
	 <pubDate>Tue, 20 Nov 2012 14:50:43 EST</pubDate>
	 <guid isPermaLink="false">news272645434</guid>
	 
</item>
<item>
     <title>Benefits seen in hormone use early in menopause</title>
   	 <description>A new study may reassure some women considering short-term use of hormones to relieve hot flashes and other menopause symptoms. Starting low-dose treatment early in menopause made women feel better and did not seem to raise heart risks during the four-year study.</description>
     <link>http://medicalxpress.com/news/2012-10-benefits-hormone-early-menopause.html</link>
	 <category>Health</category>
	 <pubDate>Wed, 03 Oct 2012 04:26:45 EST</pubDate>
	 <guid isPermaLink="false">news268456173</guid>
	 
</item>
<item>
     <title>New drug might help treat irritable bowel syndrome</title>
   	 <description>(HealthDay)—A new drug significantly reduces the abdominal pain and constipation characteristic of certain types of irritable bowel syndrome, according to two new studies.</description>
     <link>http://medicalxpress.com/news/2012-09-drug-bowel-syndrome.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 18 Sep 2012 12:20:03 EST</pubDate>
	 <guid isPermaLink="false">news267186928</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/newdrugmight.jpg" width="90" height="88" />
</item>
<item>
     <title>Study shows efficacy of new rheumatoid arthritis drug</title>
   	 <description>(Medical Xpress) -- A new study involving researchers from Karolinska Institutet demonstrates the efficacy of Tofacitinib, a new drug for rheumatoid arthritis. According to the study, which is published in The New England Journal of Medicine, the drug is just as effective as biological medicines, but unlike them can be taken in tablet form.</description>
     <link>http://medicalxpress.com/news/2012-08-efficacy-rheumatoid-arthritis-drug.html</link>
	 <category>Arthritis &amp; Rheumatism</category>
	 <pubDate>Thu, 09 Aug 2012 04:13:33 EST</pubDate>
	 <guid isPermaLink="false">news263704405</guid>
	 
</item>
<item>
     <title>New research confirms efficacy of transcranial magnetic stimulation for depression</title>
   	 <description>In one of the first studies to look at transcranial magnetic stimulation (TMS) in real-world clinical practice settings, researchers at Butler Hospital, along with colleagues across the U.S., confirmed that TMS is an effective treatment for patients with depression who are unable to find symptom relief through antidepressant medications. The study findings are published online in the June 11, 2012 edition of Depression and Anxiety in the Wiley Online Library.</description>
     <link>http://medicalxpress.com/news/2012-07-efficacy-transcranial-magnetic-depression.html</link>
	 <category>Psychology &amp; Psychiatry</category>
	 <pubDate>Thu, 26 Jul 2012 16:14:39 EST</pubDate>
	 <guid isPermaLink="false">news262537986</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/6-newresearchc.jpg" width="90" height="90" />
</item>
<item>
     <title>Steroid nasal sprays show small benefit for sinusitis: study</title>
   	 <description>(HealthDay) -- Corticosteroid nasal sprays apparently are not a silver bullet when it comes to symptom relief for acute sinusitis patients, a new review suggests.</description>
     <link>http://medicalxpress.com/news/2012-05-steroid-nasal-small-benefit-sinusitis.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 15 May 2012 11:21:43 EST</pubDate>
	 <guid isPermaLink="false">news256299674</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/steroidnasal.jpg" width="90" height="90" />
</item>
<item>
     <title>Cyberknife radiation relieves stabbing pain of facial nerve condition</title>
   	 <description>A technique that delivers highly focused beams of radiation, known as Cyberknife, can relieve the stabbing pain of the facial nerve condition trigeminal neuralgia, indicates a small study published online in the Journal of NeuroInterventional Surgery.</description>
     <link>http://medicalxpress.com/news/2012-01-cyberknife-relieves-stabbing-pain-facial.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Fri, 27 Jan 2012 04:24:34 EST</pubDate>
	 <guid isPermaLink="false">news246860664</guid>
	 
</item>
<item>
     <title>Pain characteristics suggest higher benefit from gallbladder surgery</title>
   	 <description>According to a new study in Clinical Gastroenterology and Hepatology, better understanding of a patient's abdominal pain could help physicians know which patients will benefit most from surgical removal of the gallbladder. Clinical Gastroenterology and Hepatology is the official journal of the American Gastroenterological Association.</description>
     <link>http://medicalxpress.com/news/2011-10-pain-characteristics-higher-benefit-gallbladder.html</link>
	 <category>Other</category>
	 <pubDate>Wed, 12 Oct 2011 11:37:25 EST</pubDate>
	 <guid isPermaLink="false">news237638238</guid>
	 
</item>
<item>
     <title>Most PCIs (such as balloon angioplasty) performed in US for acute indications appear warranted</title>
   	 <description>In an examination of the appropriateness of the widespread use of percutaneous coronary interventions (PCIs), researchers found that of more than 500,000 PCIs included in the study, nearly all for acute indications were classified as appropriate, whereas only about half of PCIs performed for nonacute indications could be classified as appropriate, according to a study in the July 6 issue of JAMA.</description>
     <link>http://medicalxpress.com/news/2011-07-pcis-balloon-angioplasty-acute-indications.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 05 Jul 2011 17:16:04 EST</pubDate>
	 <guid isPermaLink="false">news229104950</guid>
	 
</item>
<item>
     <title>Researchers offer hope to prolapse sufferers</title>
   	 <description>Scientists in Scandinavia have found a new way to treat sufferers of pelvic organ prolapse. Presented in the New England Journal of Medicine, their study reveals that the use of synthetic mesh can have a more beneficial effect on patients than traditional surgery. The team, led by the Karolinska Institutet in Sweden, says synthetic mesh not only restores genital anatomy but can also provide more efficient symptom relief. </description>
     <link>http://medicalxpress.com/news/2011-05-prolapse.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 17 May 2011 10:50:01 EST</pubDate>
	 <guid isPermaLink="false">news224847533</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/researcherso.jpg" width="90" height="90" />
</item>
<item>
     <title>Synthetic mesh can improve outcome of prolapse surgery</title>
   	 <description>(Medical Xpress) -- A Nordic multicentre study, headed by researchers from Karolinska Institutet, shows that pelvic organ prolapse surgery using synthetic mesh can be more effective than traditional surgery. The advantages indicated by the study mainly concern restored genital anatomy and more efficient symptom relief, although there is an associated greater risk of complications. The study is published in the renowned scientific periodical The New England Journal of Medicine.</description>
     <link>http://medicalxpress.com/news/2011-05-synthetic-mesh-outcome-prolapse-surgery.html</link>
	 <category>Other</category>
	 <pubDate>Thu, 12 May 2011 06:47:54 EST</pubDate>
	 <guid isPermaLink="false">news224401650</guid>
	 
</item>


</channel>
</rss>
